ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 207 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,000 | -11.1% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,000 | -25.0% | 400 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $12,000 | -36.8% | 400 | -20.0% | 0.00% | -40.0% |
| Q3 2017 | $19,000 | +11.8% | 500 | -16.7% | 0.01% | 0.0% |
| Q2 2017 | $17,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $17,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $17,000 | -10.5% | 600 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $19,000 | 0.0% | 600 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $19,000 | +35.7% | 600 | +20.0% | 0.01% | +16.7% |
| Q1 2016 | $14,000 | -22.2% | 500 | 0.0% | 0.01% | -64.7% |
| Q4 2015 | $18,000 | +38.5% | 500 | +25.0% | 0.02% | +183.3% |
| Q3 2015 | $13,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |